Literature DB >> 12755459

Diagnostic compared with abstinence outcomes of day treatment and contingency management among cocaine-dependent homeless persons.

Joseph E Schumacher1, Jesse B Milby, Dennis Wallace, Cathy Simpson, Sonja Frison, Cecelia McNamara, Stuart Usdan.   

Abstract

Substance use disorder diagnoses were used as a treatment outcome measure in a randomized comparison of day treatment (DT) and day treatment plus contingency management (DT+) among homeless persons with primarily crack/cocaine disorders. Participants (N = 127, DT+ = 69, DT = 58, 73.2% male, 82.7% African American) were assessed at baseline and 6-month treatment completion. Binary positive and negative diagnostic outcomes for cocaine, marijuana, and alcohol were compared by treatment group. DT+ was 2.1 times more likely to have a positive treatment outcome than DT. Concordance between diagnostic change and point and continuous abstinence outcomes were found. The use of diagnostic change can be a practical addition to drug toxicology and self-report treatment outcome measures for research and practice.

Entities:  

Mesh:

Year:  2003        PMID: 12755459     DOI: 10.1037/1064-1297.11.2.146

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  3 in total

1.  Initial abstinence status and contingency management treatment outcomes: does race matter?

Authors:  LaTrice Montgomery; Kathleen M Carroll; Nancy M Petry
Journal:  J Consult Clin Psychol       Date:  2015-03-23

2.  Effects of sustained abstinence among treated substance-abusing homeless persons on housing and employment.

Authors:  Jesse B Milby; Joseph E Schumacher; Dennis Wallace; Rudy Vuchinich; Stephen T Mennemeyer; Stefan G Kertesz
Journal:  Am J Public Health       Date:  2009-10-15       Impact factor: 9.308

3.  Toward cost-effective initial care for substance-abusing homeless.

Authors:  Jesse B Milby; Joseph E Schumacher; Rudy E Vuchinich; Michelle J Freedman; Stefan Kertesz; Dennis Wallace
Journal:  J Subst Abuse Treat       Date:  2007-05-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.